학술논문
The impact of 2018 ASCO-CAP HER2 testing guidelines on breast cancer HER2 results. An audit of 2132 consecutive cases evaluated by immunohistochemistry and in situ hybridization
Document Type
Article
Source
In Modern Pathology September 2020 33(9):1783-1790
Subject
Language
ISSN
0893-3952